🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David Morgan

Tennessee Oncology

ORCID: 0000-0002-6959-5079
MedicineEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial.

142 citations

Fangxin Hong, Richard F. Ambinder, Jonathon B. Cohen, Michael J. Robertson, Kevin A. David +12 more

N/A
0DataRank · unranked
51 citations

Michael G. Sherenian, Asel Baatyrbek kyzy, Rosario Alarcón, Amen An, Zachary Flege +11 more

18 citations

Elizabeth M. Martin, Annie M. Jarabek, David Morgan, Hannah J. Smith, Lisa A. Dailey +4 more

6 citations

Wan Chi Chang, Cassandra Almasri, Elisabet Johansson, Makenna Hurd, Verónica Velásquez +9 more

0 citations

David Morgan, Steven Park, John P. Greer, Nishitha Reddy, Kristy L. Richards +1 more

2 citations

Wei Cao, David Morgan, Roberta Sena Reis, Vidyani Suryadevara, Auriel A. Willette +4 more